<DOC>
	<DOCNO>NCT00003223</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use fenretinide may effective way prevent development cancer patient neoplasia mouth . PURPOSE : Phase II trial study effectiveness fenretinide prevent cancer patient neoplasia mouth .</brief_summary>
	<brief_title>SWOG-9507 , Fenretinide Treating Patients With Neoplasia Mouth</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy fenretinide patient oral intraepithelial neoplasia . II . Assess toxicity fenretinide patient . OUTLINE : Patients receive oral fenretinide day 1-25 every 28 day maximum 6 course . After 6 course , patient receive post-treatment biopsy . Patients exhibit disease progression unacceptable toxicity remove study . Patients follow 3 6 month . PROJECTED ACCRUAL : A total 51 patient accrue .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Retinamide</mesh_term>
	<mesh_term>Fenretinide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven oral mucosal intraepithelial neoplasia Stage II : moderate dysplasia , keratosis atypia Stage III : severe keratinize nonkeratinizing dysplasia No myelodysplastic syndrome No retinopathies PATIENT CHARACTERISTICS : See General Eligibility Criteria PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy Chemotherapy : No concurrent chemotherapy Endocrine therapy : No concurrent endocrine therapy Radiotherapy : No concurrent radiotherapy Surgery : Prior surgical ablation prior dysplastic site allow Other : At least 2 month since prior therapy toxicity Patient Characteristics Age : Not specify Performance Status : SWOG 01 Life Expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception least 1 month , , least 2 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>lip oral cavity cancer</keyword>
</DOC>